Kundenrezensionen


8 Rezensionen


3 Sterne
0

2 Sterne
0

1 Sterne
0

 
 
Durchschnittliche Kundenbewertung
Sagen Sie Ihre Meinung zu diesem Artikel
Eigene Rezension erstellen
 
 
Hilfreichste Bewertungen zuerst | Neueste Bewertungen zuerst

2 von 2 Kunden fanden die folgende Rezension hilfreich
4.0 von 5 Sternen Very Good profile on a Small Start up in Drug Dev., 3. Januar 2000
Von Ein Kunde
Working in a small start up biotech company, I found many parallels with the "Vertex Story" and the company I work for. I was able to identify with the pressure of finding a lead drug candidate (though not quite as intense as those Vertex scientists who went to Hell and back), the rallying of all the employees to do the best thing for the company, and hoping that upper management can keep raising the cash to keep us going. I might add that raising money now has become even more challenging with the advent of the Internet and the dot com companies that have taken a huge chunk of the available investment dollars. The story that unfolds in this book is a very good depiction of how difficult it is to find a drug candidate let alone one that will make it all the way through the FDA-required clinical trials. The clinical trials, although outside the scope for this book, are a significant part of getting a drug to the market and present their own set of challenges. A good book to get a pretty good feel of this is HER-2 by Robert Bazell about the road Genentech's Herceptin took before finally receiving FDA approval to treat breast cancer.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


2 von 2 Kunden fanden die folgende Rezension hilfreich
5.0 von 5 Sternen Fast-paced and Insightful, 24. März 1998
I first read this book nearly two years ago as research for a novel I was writing. Recently, I turned to it once more to pick up a few terms and found myself reading chapter after chapter!
This non-fiction tale has enough twists and turns and drama to match any thriller on the market. An informative and engaging tale of a pharmaceutical start-up and the people involved. Joshua is interesting enough that the book could have been solely about him, but he isn't the only one. All of the players in this ego-driven mega-drama are interesting on many levels.
Who would I reccomend this book to? Anyone who likes a well-told story. A background in medicine is not needed, and neither is a knowledge of business practices. All you need to enjoy this book is a brain . . . and a night light because you'll be reading this book deep into the night.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen Extraordinary look into the world of Big Pharma, 12. Januar 1998
Von Ein Kunde
Barry's Werth spent several years with the scientists and bio-venturers who formed Vertex Pharmaceuticals. The work paid off in an insightful and entertaining book. The Billion Dollar molecule is the holy grail of the researchers in today's pharmaceutical world, and this book shows how they go about attaining it. A remarkably easy book to read even if you don't know a protein from a Springsteen. The reader can find something valuable from all angles. Read it as a science book, a thriller, a business narrative, or a straight novel, you'll find delight here.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen A real insiders account of a high-tech startup, 3. Mai 1998
Barry Werth has managed in this book to capture the essence of the excitement, frustrations, suffering and satisfaction of being in a successful high-tech startup company. Having had unprecedented access to staff at Vertex and its collaborators, he has managed to reconstruct events from all angles. Werth presents his story in a compelling dramatic style, from the heady heights of scientific discovery, to the depths of VC capriciousness.
This book is highly suggested reading in our new startup!
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen Excellent book, vivid insights into biotech hustle, 6. Januar 1999
A well-told, vivid story about real life drug development, executed with a sharp observer's eye and an even hand. Hardly a gushing account of medical miracles in the making, but by no means industry bashing either. Rather, an inside look at real people in a fascinating world. This book never quite got the critical acclaim that it deserved.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen A excellent cross between business text and fiction, 22. März 1999
Von Ein Kunde
I read this book a couple of years ago and enjoyed it very much. Over time I have forgetten about it. But lately I've been doing research into new business creation and remembered this well written book. Many of the dry lessons of academic research are presented in a case study that reads like fiction.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen Great book.Well written. Very informative re;pharmaceuticals, 13. April 1998
I read this book a few years ago and mention it to many of my associates in academia. It is a must read for people who are professors at pharmacy schools.
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


5.0 von 5 Sternen This is one hell of a book; an epic saga, a page-turner, 14. Oktober 1998
Von Ein Kunde
Good info. on biotech, too, for the educated layperson
Helfen Sie anderen Kunden bei der Suche nach den hilfreichsten Rezensionen 
War diese Rezension für Sie hilfreich? Ja Nein


Hilfreichste Bewertungen zuerst | Neueste Bewertungen zuerst

Dieses Produkt

Nur in den Rezensionen zu diesem Produkt suchen